Get Plus

Sign in to baba News

One account across the web, iPhone and Android — your subscription follows it.

or use an email code

Search stories

Type at least two characters. Results come from every newsroom baba reads.

↑↓ to move · ↵ to open · esc to close

Sign in to baba News

Sign in to keep asking. News Plus removes the daily limit.

or use an email code

IceEconomy

Wall Street Futures Dip Amid AI Chip Demand Concerns; Nvidia, Micron in Focus

Translated & summarized from Ice by baba

BusinessNeutral tone

Hebrew · 1 newsroom

Wall Street futures indicate a lower open on Monday, with Nasdaq, S&P 500, and Dow Jones futures all declining due to concerns over AI company valuations and chip demand. Nvidia's stock fell 5% pre-market ahead of its earnings report, while Micron also dropped 8% amid memory chip market worries. Israeli chip-related stocks like Tower Semiconductor and Camtek saw significant pre-market losses, though Teva Pharmaceutical rose on FDA drug approval news. Investor sentiment is further dampened by rising bond yields and the VIX volatility index.

The story in 6 lines · by baba

  • Wall Street futures signal a downbeat start to the trading week amid AI and chip demand concerns.
  • Nvidia stock drops 5% pre-market ahead of key earnings report and interim management assessment.
  • Micron shares fall 8% on fears of a future shift in the memory chip supply-demand balance.
  • Israeli chip firms Tower Semiconductor and Camtek decline significantly in pre-market trading.
  • Teva Pharmaceutical stock rises 1.8% on FDA approval for a drug from a recently acquired company.
  • Bond yields remain high, and the VIX volatility index climbs, signaling increased investor apprehension.

Wall Street is poised to open the trading week with declines on Monday, as concerns over the valuation of artificial intelligence companies and the future demand for chips continue to weigh on technology stocks. Nasdaq futures are down approximately 1.4%, S&P 500 futures have lost about 0.7%, and Dow Jones futures are retreating by roughly 0.2%. This negative trend follows a weak performance on Friday, where the Nasdaq fell about 0.9%, the S&P 500 dropped around 0.4%, and the Dow Jones managed a slight 0.1% gain.

Nvidia is once again at the center of trading, with its stock down about 5% in pre-market activity ahead of its financial report due after market close on Tuesday. This will be the first report since the departure of founder and CEO Jensen Huang, and investors will be scrutinizing the interim management's ability to maintain growth momentum, in addition to revenue and profitability. The market anticipates revenues of around $108 billion, with the demand for AI accelerators and future quarterly forecasts expected to be key focus areas. Ahead of the results, several investment firms have lowered their price targets for Nvidia's stock, with Mizuho reducing its target from $250 to $220 and UBS cutting its target from $300 to $240. Both firms maintained positive recommendations, but the adjustments reflect increased uncertainty surrounding the company. Nvidia has lost about 13% in the past week.

Micron's stock is down approximately 8% in pre-market trading due to worries about future shifts in the supply-demand balance for memory chips. While data center investments continue to support demand, investors are concerned about the industry's capacity expansion in the coming years. This pressure is also evident in Asia, with sharp declines in SK Hynix and Samsung shares. Israeli companies Tower Semiconductor and Camtek are also seeing significant drops, down about 10% and 8% respectively in pre-market trading, with Nova also weakening by about 5.5%. These companies, exposed to various aspects of the chip industry, reflect the broader pressure on the sector. Mobileye is also down around 3.4%.

In contrast, Teva Pharmaceutical is up about 1.8% in pre-market trading following reports of U.S. Food and Drug Administration (FDA) approval for a drug developed by a recently acquired company. This development could support Teva's expansion in innovative drug activities, a key growth area for the company. Other stocks drawing attention include Take-Two Interactive, up about 3.3% ahead of the planned launch of its video game GTA 6 later this week. Johnson & Johnson is up about 2% on news of a biotechnology acquisition, while Armark is down about 6% after reporting adjusted earnings below analyst expectations.

Beyond stock movements, investors are monitoring the U.S. bond market, with the ten-year Treasury yield at around 5.14%, a level that pressures growth stock valuations and heightens market sensitivity to interest rate expectations. The possibility that the Federal Reserve may maintain restrictive monetary policy adds to the uncertainty. The VIX volatility index is climbing about 8% to 20.8 points, indicating increased investor apprehension. Meanwhile, WTI crude oil is down about 1% to around $87.7 per barrel, and Bitcoin has retreated about 1.5% to approximately $64,300.

Markets outside the U.S. are also showing a negative picture. Japan's Nikkei index lost about 2.4% today, driven by tech stock declines, and European markets are experiencing moderate drops, with the Euro Stoxx 50 index down about 0.3%.

IceOther · Tel Aviv

Sign in to baba News

Sign in to follow newsrooms, topics and people.

or use an email code

EconomyTopic

Sign in to baba News

Sign in to follow newsrooms, topics and people.

or use an email code

Mentioned

Related stories · 2

Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.

Open the Wire